These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. [Current findings on adrenergic receptors and blocking agents]. Endoh M Nihon Rinsho; 1982; 40(11):2471-6. PubMed ID: 6130173 [No Abstract] [Full Text] [Related]
25. Thyroid hormone and adrenergic signaling in the heart. Kim B; Carvalho-Bianco SD; Larsen PR Arq Bras Endocrinol Metabol; 2004 Feb; 48(1):171-5. PubMed ID: 15611830 [TBL] [Abstract][Full Text] [Related]
26. [Interrelation between the alpha- and beta-receptor activating actions of catecholamines in the tracheal muscle]. Takeshi O Nihon Heikatsukin Gakkai Zasshi; 1969 Sep; 5(3):170-5. PubMed ID: 4402685 [No Abstract] [Full Text] [Related]
27. [The beta-blocking drugs in hyperthyroidism. I. Effects on the cardiovascular syndrome]. Ghidini O; Bellotti G; De Gregori ME; Salazzari G; Giardina F Minerva Med; 1971 Mar; 62(26):1363-73. PubMed ID: 4396565 [No Abstract] [Full Text] [Related]
28. Comparison of the anti-arrhythmic action and beta-blocking potency of LB 46 and (--)-propranolol. Flórez J; Arconada JA Arch Int Pharmacodyn Ther; 1971 Mar; 190(1):199-207. PubMed ID: 4396347 [No Abstract] [Full Text] [Related]
29. Effect of adrenergic receptor blockade of the tachycardia of thyrotoxicosis and anxiety state. Turner P; Granville-Grossman KL Lancet; 1965 Dec; 2(7426):1316-8. PubMed ID: 4165805 [No Abstract] [Full Text] [Related]
30. Role of the autonomic nervous system in the resting tachycardia of experimental hyperthyroidism. Cairoli VJ; Crout JR J Pharmacol Exp Ther; 1967 Oct; 158(1):55-65. PubMed ID: 6054081 [No Abstract] [Full Text] [Related]
31. Hyperthyroid myopathy and the response to treatment. Olson BR; Klein I; Benner R; Burdett R; Trzepacz P; Levey GS Thyroid; 1991; 1(2):137-41. PubMed ID: 1688015 [TBL] [Abstract][Full Text] [Related]
32. New perspectives on thyroid hormone, catecholamines, and the heart. Klein I; Levey GS Am J Med; 1984 Feb; 76(2):167-72. PubMed ID: 6695944 [No Abstract] [Full Text] [Related]
33. Thyrotoxicosis: comparison of effects of thyroid ablation and beta-adrenergic blockade on metabolic rate and ventilatory control. Zwillich CW; Matthay M; Potts DE; Adler R; Hofeldt F; Weil JV J Clin Endocrinol Metab; 1978 Mar; 46(3):491-500. PubMed ID: 221522 [TBL] [Abstract][Full Text] [Related]
36. Supraventricular arrhythmias and the relation to thyroid dysfunction in a group of Syrian patients. Hadidy S; Issa F; Hourani N Trop Geogr Med; 1986 Jun; 38(2):158-61. PubMed ID: 2426847 [TBL] [Abstract][Full Text] [Related]
37. [The role of the adrenergic beta-receptors in emotional tachycardia; radiotelemetric studies on ski jumpers]. Blatter K; Imhof P Schweiz Z Sportmed; 1969; 17(4):131-49. PubMed ID: 4395645 [No Abstract] [Full Text] [Related]
38. [Therapeutic effect of beta-blocking agents on tachycardia due to hyperthyroidism]. Terajima F; Hirose Y; Miyazaki T; Miyakawa S; Inokawa K Horumon To Rinsho; 1970 Jan; 18(1):79-82. PubMed ID: 4392012 [No Abstract] [Full Text] [Related]
39. Beta blockade in the management of thyrotoxicosis. Wilkinson R J Clin Hosp Pharm; 1983 Dec; 8(4):323-32. PubMed ID: 6141183 [No Abstract] [Full Text] [Related]
40. Possible potentiation of haloperidol neurotoxicity in acute hyperthyroidism. Lake CR; Fann WE Br J Psychiatry; 1973 Nov; 123(576):523-5. PubMed ID: 4766648 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]